CDSCO License for Flotation therapy bed, neonatal
Medical Device Information
Intended Use
Intended to minimize pressure points on neonatal patient's body by providing contact with as much of the body surface as possible, typically through a mattress that contains a large volume of constantly moving media, e.g., water, air, or mud that lifts the patient to simulate a floating effect.

Comprehensive Guide to CDSCO Licensing for Neonatal Flotation Therapy Beds (Class B)
As a specialized medical device designed to minimize pressure points for neonatal patients through a unique flotation mechanism, the Flotation Therapy Bed, Neonatal plays a critical role in neonatal care. Categorized under physical support devices and classified as Class B risk by CDSCO, this device requires stringent regulatory compliance before entering the Indian market.
With over 25 years of expertise assisting 500+ companies in securing CDSCO licenses, we provide you with an authoritative, step-by-step guide tailored specifically for this device type and risk classification.
CDSCO Regulatory Framework for Neonatal Flotation Therapy Beds
The Central Drugs Standard Control Organization (CDSCO) governs medical device approvals in India under the Medical Device Rules, 2017. Your flotation therapy bed falls under Class B, meaning moderate risk and regulatory oversight primarily at the state level.
The regulatory framework mandates manufacturers to obtain a Manufacturing License (MD5) before commencing production. This license ensures your device meets safety, quality, and performance criteria aligned with Indian regulations and international standards.
To initiate your application, you must submit documents and applications through the CDSCO MD Online Portal.
Risk Classification and License Requirements
The Flotation Therapy Bed, Neonatal is classified as Class B due to its physical support function and potential impact on vulnerable neonatal patients. This classification dictates the licensing pathway:
- License Type: MD5 (Manufacturing License for Class A and B devices)
- Application Form: MD3
- Licensing Authority: State Licensing Authority
- Typical Processing Time: 3-4 months
Manufacturers must first obtain a Test License (Form MD13) before applying for MD5.
For detailed classification insights, refer to the Medical Device Classification guide.
Manufacturing License Process (MD5)
The MD5 license process for your neonatal flotation therapy bed involves several key stages:
- Test License Application (Form MD13): Obtain a test license to manufacture the device on a trial basis. This phase allows initial product testing and validation.
- Product Testing: Conduct mandatory tests at CDSCO-approved testing laboratories. For a flotation therapy bed, tests typically include biocompatibility, electrical safety (if applicable), and mechanical integrity. Use the Testing Laboratories list to select an authorized lab.
- Document Preparation: Compile comprehensive documentation including Device Master File, Plant Master File, Risk Management File, Quality Management System (QMS) documents, and more.
- Application Submission: File your MD5 application through the CDSCO portal.
- Audit by Notified Body: Undergo a mandatory audit by a CDSCO-recognized notified body. Find the Notified Bodies List here.
- Query Resolution: Address any observations or queries raised during the audit and evaluation.
- License Grant: Upon satisfactory compliance, the State Licensing Authority issues the MD5 license.
Manufacturing License Documents Required
To streamline your MD5 application, ensure the following documents are meticulously prepared:
- Company Constitution Proof: Incorporation certificate, partnership deed, or equivalent.
- Premises Ownership Proof: Lease agreement or property ownership documents.
- Technical Staff Details: Qualification and experience certificates of key personnel.
- Fire NOC: No objection certificate from the fire department.
- Pollution Control NOC: Environmental clearance or consent to operate.
- Device Master File: Detailed technical specifications and design information. Our Device Master File guide provides an in-depth look.
- Plant Master File: Information on manufacturing facilities and equipment. See our Plant Master File Guide.
- Essential Principles Checklist: Evidence of conformity to essential safety and performance principles.
- Risk Management File: Documentation of identified risks and mitigation strategies. Learn how to implement risk management.
- Test Reports: Laboratory test certificates validating device safety and performance.
- Labels and Instructions for Use (IFU): Samples reflecting compliance with labeling regulations.
- Quality Management System Documents: ISO 13485 certification and internal quality policies.
Import License Process (MD15)
If you plan to import neonatal flotation therapy beds into India, an MD15 Import License is mandatory. This license is issued by the Central Licensing Authority with a longer processing time of approximately 5-6 months.
The import process involves:
- Document preparation including Manufacturing License from the country of origin, Free Sale Certificate, ISO 13485:2016, CE Certificate, Device Master and Plant Master Files.
- Submission of application on the CDSCO MD Online Portal.
- Resolution of any regulatory queries.
- License grant for import.
For comprehensive guidance, consult our Import License Guide.
Import License Documents Required
Key documents for MD15 application include:
- Manufacturing License from the exporting country
- Free Sale Certificate
- ISO 13485:2016 Certification
- CE Certificate (if applicable)
- Device Master File
- Plant Master File
- Wholesale License for import
- Company Constitution Proof
Timeline and Processing Duration
For manufacturing the neonatal flotation therapy bed:
- Test License (MD13): 1.5 to 2 months
- Product Testing: 3 to 4 weeks depending on lab throughput
- MD5 Application & Audit: 1.5 to 2 months
Total Estimated Time: Approximately 3 to 4 months from start to license grant.
Keep in mind that timely and accurate document submission, along with prompt responses to audit queries, can significantly reduce processing delays.
Government Fees and Costs
The fee structure for MD5 licensing is as follows:
- Application Fee: Rs 5,000 per application
- Product Fee: Rs 500 per product
Additional costs to factor in include:
- Testing laboratory charges (varies by test scope)
- Notified body audit fees
- Consultancy and documentation preparation (if outsourced)
Investing in thorough preparation upfront helps avoid costly rework and accelerates approval.
Common Challenges and Solutions
Manufacturers often face hurdles such as:
- Incomplete Documentation: Missing or inadequate files delay review. Solution: Use detailed checklists aligned with CDSCO requirements.
- Test Failures: Non-conformance in product testing. Solution: Pre-audit internal testing and quality checks.
- Audit Non-compliance: Gaps in QMS or facility readiness. Solution: Conduct mock audits and train staff.
- Delays in Query Responses: Slow communication prolongs timelines. Solution: Establish a dedicated regulatory liaison team.
Our consultancy experience highlights that proactive risk management and compliance readiness are crucial to overcoming these challenges.
Expert Consultation and Support
Navigating the CDSCO licensing landscape for neonatal flotation therapy beds demands specialized knowledge. Our team of regulatory experts offers:
- Tailored documentation support
- Audit preparation and accompaniment
- Liaison with CDSCO and notified bodies
- Comprehensive training on regulatory updates
Engaging expert help can reduce your timeline and boost your chances of approval.
Getting Started with Your CDSCO License Application
- Assess Your Device Classification: Confirm the Class B status and regulatory requirements.
- Prepare Initial Documentation: Gather company and facility proofs, technical staff details, and develop your Device and Plant Master Files.
- Apply for Test License (MD13): Submit your test license application via the CDSCO MD Online Portal to commence manufacturing trials.
- Schedule Product Testing: Engage a CDSCO-approved testing laboratory early to avoid bottlenecks.
- Develop QMS and Risk Management Files: Ensure your quality processes are robust and compliant.
- Plan for the Audit: Coordinate with a notified body from the official Notified Bodies List for audit scheduling.
- Submit MD5 License Application: Once test license and testing are complete, apply for your manufacturing license.
- Prepare for Query Resolution: Allocate resources to promptly address any CDSCO or audit queries.
By following this structured approach, you position your neonatal flotation therapy bed for a successful market entry in India.
For further personalized assistance, connect with our regulatory consultants who have guided over 500 companies through the CDSCO licensing process efficiently and compliantly.